None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For laparoscopic sleeve gastrectomy: 1. Age 18-70 years old, gender not restricted; 2. Meet the surgical indications as stipulated in the "Chinese Guidelines for Surgical Treatment of Obesity and Metabolic Diseases (2024 Edition)" [9] and have been admitted to our hospital to plan for laparoscopic sleeve gastrectomy; 3. Complete clinical data of the patient. For VATS lobectomy: 1. Age 18-70 years old, gender not restricted; 2. Meet the surgical indications for lobectomy and the results of pulmonary function tests show that the patient can tolerate lobectomy; have been admitted to our hospital to plan for VATS lobectomy, as follows: 1) Non-small cell lung cancer in stage I/II and some stage III; 2) Other malignant tumors requiring lobectomy; 3) Benign lesions where lesion resection or pulmonary wedge resection is difficult due to the lesion being close to the hilum, involving a large part or the entire lung lobe. 3. Complete clinical data of the patient.
Exclusion criteria
Exclusion criteria: Regarding laparoscopic sleeve gastrectomy: 1. It has one of the surgical contraindications listed in the "Chinese Guidelines for Surgical Treatment of Obesity and Metabolic Diseases (2024 Edition)": a. A clear diagnosis of non-obese type 1 diabetes; b. Pregnant women with diabetes and certain special types of diabetes; c. Patients who abuse drugs, are addicted to alcohol or have mental and psychological disorders that are not well controlled; d. Those with intellectual disabilities or immature intelligence, and whose behavior cannot be self-controlled; e. Those whose expectations for surgical weight loss do not match the actual situation; f. Those unwilling to bear the potential risks of surgical complications; g. Those who cannot cooperate with the changes in diet and lifestyle after surgery and have poor compliance; h. Those with poor overall condition and are unable to tolerate general anesthesia or surgery. 2. Has used hypoglycemic drugs or statin lipid-lowering drugs before or currently; 3. Has undergone gastric or intestinal surgery before; 4. Has suffered from liver and gallbladder diseases other than alcoholic fatty liver disease before or currently; 5. Has suffered from chronic organic intestinal diseases before or currently; 6. Has a history of excessive alcohol consumption: for men, the equivalent ethanol intake over the past 12 months is greater than 30g/d, and for women, it is greater than 20g/d; 7. Had acute gastroenteritis within one month before the surgery; 8. Used antibiotics or acid-suppressing drugs within one month before the surgery; 9. Has mental or neurological disorders, and cannot express one's will correctly; 10. Has other serious diseases that affect the evaluation of this study and cannot cooperate; 11. Cannot understand the procedures and methods of this clinical study, refuses to participate and refuses to sign the informed consent form. For thoracoscopic lobectomy: 1. Central lung cancer with mediastinal lymph node metastasis and invasion or extensive spread; 2. Severe dense adhesions in the thoracic cavity, including severe inflammatory lesions and pleural fusion; 3. Stage IIIB - IIIB NSCLC with cancer tissue invading the main bronchus or the main pulmonary artery; 4. The results of pulmonary function tests are intolerable for lobectomy; 5. Unable to tolerate one-lung ventilation; 6. Large tumors (diameter > 6 cm); 7. Mental or neurological disorders, unable to express wishes correctly; 8. Other serious diseases that affect the evaluation of this study cannot be controlled; 9. Unable to understand the procedures and methods of this clinical study and refuse to participate and refuse to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Event-free survival rate ; | — |
Secondary
| Measure | Time frame |
|---|---|
| The inoperative performance of medical staplers;Operational convenience;The incidence of postoperative anastomotic fistula/ stump fistula complications;Duration of the surgery;Postoperative hospital stay duration;Post-operative fatigue of medical staff; | — |
Countries
China
Contacts
Huashan Hospital, Fudan University, China